Current Trials

We are currently conducting the following trials :

Respiratory Syncytial Virus (RSV) Vaccine

Respiratory syncytial virus (RSV) is a contagious virus that infects the respiratory tract. It's common in children and adults, but can be especially serious for infants, the elderly, and people with weakened immune systems. Symptoms can include but not limited to Runny nose, Coughing, Sneezing, Fever, Decreased appetite, Wheezing, Irritability, Decreased activity, and Breathing difficulties.

Qualifications

• 

  Aged 6 months to < 22 months
  

  Participants who are healthy as determined by medical evaluation including medical history.
  

  Born at full term of pregnancy (≥ 37 weeks)
  

  Participant and parent(s)/LAR are willing and able to comply with study-related procedures

Compensation

• 

  Patient compensation is available for time.

Join our Patient List

Crohn’s :

CD can be broadly defined as an inflammatory disease affecting any part of the GI tract from mouth to anus, though it commonly affects the ileum and colon. Importantly, CD is characterized by the involvement of the entire gut wall, with an anatomical location in any part of the GI tract and a tendency to present complications such as fistulae and strictures. There are several theories as to contributing factors for CD pathogenesis. The complex etiology includes an interplay between genetics, bacteria, and environmental factors.

Qualifications

• 

  18 years and older
  

  Diagnosis of Crohn’s Diseases for at least 3 months prior to screening.
  

  Able to participate fully in all aspects of this clinical trial.
  

  Written informed consent must be obtained and documented.

Compensation

• 

  Patient compensation is available for time.

Join our Patient List

asthma:

This is a decentralized study to evaluate the efficacy and safety of study inhaler taken as needed, for up to 12 months. Participants 12 years of age and older with asthma will be recruited with all visits conducted virtually.

Qualifications

• 

  Patient must be 12 years old or older at the time of consent
  

  Diagnosis of asthma by a prescribing healthcare professional.
  

  Capable of giving signed eICF (including assent with parental/ legal guardian consent in 12 to < 18 year olds)

Compensation

• 

  Patient compensation is available for time.

Join our Patient List

Pediatrics Migraine :

A migraine day is defined as a calendar day (12:00am to 11:59pm) in which the subject experiences a migraine attack that starts, ends or recurs within 24 hours and lasts for ≥1 hour (if untreated) or ≥30 minutes (if interrupted with rescue medication). Pain persisting for more than 1 calendar day (≥24 hours) after initial onset will be considered as a new, distinct headache day. Monthly migraine days is defined as the number of migraine days within 28 days or 4 weeks.

Qualifications

• 

  Subjects will be healthy male or female children 6 to 17 years of age (inclusive) at Screening
  

  A PedMIDAS Disability score of > 10 and < 50 to be eligible for the study.
  

  Willing and able to comply with study-related procedures

Compensation

• 

  Patient compensation is available for time.

Join our Patient List

Pediatric Covid-Vaccine:

This pediatric study is intended to confirm safety in infants between 12 weeks to < 12 years of age and to bridge immunogenicity between infants/children and adults (> 18 years of age) enrolled in adult studies. It is necessary to demonstrate non-inferiority of the induced immune response in infants and children compared with that in adults to infer vaccine effectiveness in this age group.

Qualifications

• 

  Male and female subjects age 12 weeks to 11 years, inclusive
  

  Born at ≥ 37 weeks gestation (Part 1) or ≥ 34 weeks gestation(Part 2), with a minimum birth weight of 2.5 kg
  

  Willing and able to comply with study-related procedures

Compensation

• 

  Patient compensation is available for time.

Join our Patient List

And more...

Past Trials:

If you’d like to register for any of the above studies, click the 'Join Our Patient List' button to register.

If you have any questions, please email:
‍info@clinicalresearchofcalifornia.com info@clinicalresearchofcalifornia.cominioiiiiiinfo@clinicalresearchofcalifornia.cominfo@clinicalresearchofcalifornia.com